By Topic

Europe

Coronavirus

This week’s IGM European Economic Experts Panel statements: A) Even if the mortality of COVID-19 proves to be limited (similar to the number of flu deaths in a regular season), it is likely to cause a major recession. B) The economic effects of COVID-19 coming from reduced spending will be larger than those coming from disruptions to supply chains and illness-related workforce reductions. C) The economic policy institutions of the Eurozone are well equipped to ameliorate the potential economic damage from COVID-19. 
US

Coronavirus

This week’s IGM Economic Experts Panel statements: A) Even if the mortality of COVID-19 proves to be limited (similar to the number of flu deaths in a regular season), it is likely to cause a major recession. B) The economic effects of COVID-19 coming from reduced spending will be larger than those coming from disruptions to supply chains and illness-related workforce reductions. 
US

Health Insurance Subsidies

This week’s IGM Economic Experts Panel statements: A) Expanding health insurance to more people through the ACA’s public subsidies and Medicaid expansion will reduce total healthcare spending in the economy. B) Expanding health insurance to more people through the ACA’s public subsidies and Medicaid expansion will generate gains in the health and well-being of the newly insured that exceed the costs. 
US

Health-Care Licensing

This week’s IGM Economic Experts Panel poll statement: Loosening current licensing restrictions on the range of services that nurses, physician assistants, dental hygienists and pharmacists are permitted to perform would help patients on balance, because the additional safety risks would be small compared to the decreased costs in waiting time and fees. 
US

Mandatory Medicare I

This week’s IGM Economic Experts Panel statements: a) Replacing the current US health insurance system (including employer-based health insurance, ACA exchange policies, and Medicaid) with universal ‘Medicare for All’ (mandatory enrollment in a modified version of the existing traditional Medicare program with drug coverage and no cost-sharing of any form, and current Medicare reimbursement rates) funded by federal taxes would lead to improved access to healthcare for a meaningful subset of the population. b) Replacing the current US health insurance system as outlined in a) would lead to longer waiting times for healthcare for a meaningful subset of the population. 
US

Mandatory Medicare II

This week’s IGM Economic Experts Panel statements: A) Replacing the current US health insurance system (including employer-based health insurance, ACA exchange policies, and Medicaid) with universal ‘Medicare for All’ (mandatory enrollment in a modified version of the existing traditional Medicare program with drug coverage and no cost-sharing of any form, and current Medicare reimbursement rates) funded by federal taxes would lead to lower aggregate medical debt among patients. B) Replacing the current US health insurance system as outlined in a) would lead to lower aggregate innovation in the pharmaceutical industry. C) Replacing the current US health insurance system as outlined in a) would improve health outcomes for the majority of the population.